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Background
The success of systemic adoptive T cell transfer lies in
the capacity of the antigen-experienced cytotoxic T lym-
phocytes to access and persist within the tumour micro-
environment. The mimicking of tertiary lymphoid
structures that promote a protective immune response
against cancer can be achieved using an injectable bio-
compatible matrix that releases anti-tumour, proliferat-
ing T lymphocytes. Prime candidates for this application
are liquid, chitosan-based, biocompatible thermogels
which rapidly gelify at physiological temperatures.
Therefore, we aimed to fine-tune an injectable chitosan-
based thermogel formulation that would provide an
environment permitting the three-dimensional prolifera-
tion and release of T lymphocytes whose activation state
can be influenced by the surrounding conditions. We
have developed a novel chitosan formulation that is
both cytocompatible and injectable, and which has ideal
mechanical properties and porosity for T cell encapsula-
tion and growth. With such promising characteristics,
we hypothesize that the injection of these T lympho-
cytes loaded hydrogels into the tumour microenviron-
ment will provide a means for a continuous delivery of
T lymphocytes towards the reprogramming of inflam-
mation mechanisms and the reduction of tumour
burden.
Materials and methods
Novel T cell cytocompatible chitosan thermogels were
prepared using combinations of gelling agents. Their
rheological properties, mechanical strengths, pH, osmol-
ality, and morphology were evaluated. Three formula-
tions were selected for human T cell encapsulation.
Biocompatibility was assessed using live/dead staining
and fluorescent microscopy. Thermogel- and superna-
tant-derived T cells and tumour infiltrating lymphocytes
were immunophenotyped over time using flow
cytometry.
Results and conclusions
We have optimized thermogel formulations supporting
the encapsulation of T lymphocytes in vitro. Use of flow
cytometry and microscopy demonstrates which novel
thermogel formulation is best suited for cell viability,
proliferation, and escape over time, along with the main-
tenance of T lymphocytes cellular phenotype and an
activation status that can be influenced by surrounding
conditions. Our injectable three-dimensional T lympho-
cyte cultures may serve to complement current adoptive
cell transfer immunotherapies.
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